Caicun Zhou
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Shengxiang RenXuefei LiChunxia SuTao JiangChao ZhaoGuanghui GaoGerald Schmid‐BindertXiaoxia Chen
- Topics
- Lung Cancer Treatments and Mutations (78 papers)Cancer Immunotherapy and Biomarkers (28 papers)Cancer Genomics and Diagnostics (24 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Caicun Zhou
131 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 1.7k
- Molecular Biology 1.4k
- Cancer Research 1.4k
- Pathology and Forensic Medicine 275
Countries citing papers authored by Caicun Zhou
This map shows the geographic impact of Caicun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caicun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caicun Zhou more than expected).
Fields of papers citing papers by Caicun Zhou
This network shows the impact of papers produced by Caicun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caicun Zhou. The network helps show where Caicun Zhou may publish in the future.
Co-authorship network of co-authors of Caicun Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Caicun Zhou. A scholar is included among the top collaborators of Caicun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caicun Zhou. Caicun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 15 | |
| 9 | 0 | |
| 10 | Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trialbreakdown → | 126 |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 23 | |
| 15 | 25 | |
| 16 | 2 | |
| 17 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapybreakdown → | 367 |
| 18 | 24 | |
| 19 | 6 | |
| 20 | Selection and establishment of gefitinib-resistant PC9 cell line and its gene expression profile | 2 |
About Caicun Zhou
Caicun Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 136 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (78 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Cancer Genomics and Diagnostics (24 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.7k citations) and Pulmonary and Respiratory Medicine (1.9k citations). Caicun Zhou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shengxiang Ren, Xuefei Li, Chunxia Su, Tao Jiang, Chao Zhao, Guanghui Gao, Gerald Schmid‐Bindert, Xiaoxia Chen, Songwen Zhou and Xiaoxia Chen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.